Andrew R. Adams
Mairs & Power Growth Fund
Mairs & Power Growth Fund Inspire Medical Systems Inc stake
total: 96
Mairs & Power Growth Fund INSP trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 2
- Held since:
- 2021 Q2
- Held for:
- 8 quarters
- Latest activity:
- 2023 Q2
According to 2026 Q2 report, Mairs & Power Growth Fund doesn't hold any Inspire Medical Systems Inc (INSP) shares. To date, the estimated cost basis is nearly $193.26 for "buy" trades and estimated average "sell" price is $242.55. Mairs & Power Growth Fund first purchased INSP in 2021 Q2, initially acquiring 96,000 shares. Since the initial investment in Inspire Medical Systems Inc (INSP), Mairs & Power Growth Fund has made 3 more transactions.
When did Mairs & Power Growth Fund sell Inspire Medical Systems Inc (INSP)?
Mairs & Power Growth Fund sold off the entire Inspire Medical Systems Inc (INSP) position in 2023 Q2.
When did Mairs & Power Growth Fund buy Inspire Medical Systems Inc (INSP)?
Mairs & Power Growth Fund first invested in Inspire Medical Systems Inc (INSP) in 2021 Q2 at the reported quarter-end price of $193.26 per share.
What's the cost basis of Mairs & Power Growth Fund's INSP stake?
The estimated cost basis for Inspire Medical Systems Inc (INSP) stake is around $193.26 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $193.26
- Weighted AVG sell price:
- $242.55
Mairs & Power Growth Fund's historical trades in Inspire Medical Systems Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$234.07
|
|
-100% (-44,000)
|
-0.23%
|
|
2023 Q1
|
0.23%
|
44,000
|
$234.07
|
$10,299,080
|
-26.67% (-16,000)
|
-0.09%
|
|
2022 Q1
|
0.28%
|
60,000
|
$256.69
|
$15,401,400
|
-37.50% (-36,000)
|
-0.16%
|
|
2021 Q2
|
0.34%
|
96,000
|
$193.26
|
$18,552,960
|
new
|
+0.34%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.